Presentation TCT 2018 Is There a Standard Work-Up for Stent Thrombosis? Hematology, Imaging, and More Presenter: Fernando Alfonso, Azeem Latib, Robert A. Byrne September 22, 2018
Presentation TCT 2018 The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease Presenter: Jeroen J. Bax, Stephan Windecker, Robert A. Byrne September 21, 2018
Presentation ESC 2018 ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction Presenter: Robert Byrne August 29, 2018
News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Conference News ESC 2018 Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients Michael O'Riordan August 28, 2018
News Conference News ESC 2018 MATRIX: 1-Year Results Confirm Superiority of Transradial PCI Michael O'Riordan August 25, 2018
News Conference News EuroPCR 2018 Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study Michael O'Riordan May 29, 2018
News Daily News Uncomplicated TLR After PCI Linked With Worse Mortality Michael O'Riordan April 20, 2018
Presentation TCT 2017 Flash Debate: Bioresorbable Scaffolds Should Rarely be Used Outside of Carefully Controlled Research Studies! Presenter: Sanjay Kaul, Tullio Palmerini, Robert A. Byrne November 01, 2017
Presentation TCT 2017 Yukon and Coroflex ISAR Polymer-Free DES: Clinical Outcomes and Future Directions Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Robert A. Byrne November 01, 2017
Presentation TCT 2017 Debate: ABSORB Is Likely Finished - The Limitation of the Technology Can Not Be Overcome Presenter: Stephen G. Ellis, Takeshi Kimura, Robert A. Byrne October 31, 2017
Presentation TCT 2017 DCB Preclinical Perspectives: Mechanisms and Experimental Safety and Efficacy of Older, Current, and Futuristic DCB Presenter: Robert A. Byrne, Ran Kornowski, Juan F. Granada October 30, 2017
Presentation TCT 2017 Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy Presenter: Robert A. Byrne, Ran Kornowski, Ron Waksman October 30, 2017
Presentation TCT 2017 Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB Presenter: Robert A. Byrne, Ran Kornowski, Fernando Alfonso October 30, 2017
Presentation TCT 2017 Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow? Presenter: Robert A. Byrne, Ran Kornowski, Bernardo Cortese October 30, 2017
Presentation TCT 2017 Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art Presenter: Robert A. Byrne, Ran Kornowski, Bruno Scheller October 30, 2017
Presentation TCT 2017 Topic 4: At the Cusp of Diminishing Returns for CV Therapies - Personalized Approaches and New Frontiers Presenter: Robert A. Byrne, Gregg W. Stone, Robert A. Harrington October 30, 2017
Presentation TCT 2017 Topic 3: Chronic Total Occlusion PCI - What Level of Evidence Is Required for Widespread Acceptance: Hard Endpoints vs QOL Measures Presenter: Robert A. Byrne, Gregg W. Stone, J. Aaron Grantham October 30, 2017
Presentation TCT 2017 Topic 2: Outcomes Without a Clear Mechanism (Radial Mortality Benefit, Aspirin/Ticagrelor Interaction, and More) Presenter: Robert A. Byrne, Gregg W. Stone, Robert A. Harrington October 30, 2017
Presentation TCT 2017 Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More Presenter: Robert A. Byrne, Gregg W. Stone, Aaron V. Kaplan October 30, 2017